Cambrex Corp (NYSE:CBM)
CAPS Rating:
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
Investors Writing for Investors
A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Reading EPS100Momentum's blog led me to CBM and the news of the company's intent to distribute a large dividend of $13.50 - $14.50 at an unspecified date in the future.
After watching SMG on the news of it's special one-time $8 dividend, there can be little doubt that CBM will appreciate considerably as the record date for the dividend approachs.